With a rationale for achieving adequate residual ridge that reduces the need for future ridge augmentation to obtain optimal, functional, and esthetic results, this study was conducted to determine the efficacy of PRF and β‑TCP‑Cl in preserving extraction sockets. The resorbable viable bone graft, beta-tricalcium phosphate with type I collagen, has been utilized in orthopedic and other surgical specialties for almost 30 years. During the breakdown and resorption of the graft, no cytotoxic compounds are released and it disintegrate clinically, histologically, and radiographically. It provides a sufficient period to place a dental implant in the grafted site. It is commercially available as a Resorbable Tissue Replacement (RTR) cone (Septodont, Saint‑Maur‑des‑Fosses, France) for the reconstruction of bone defects in maxillofacial and dental surgeries.